VAPE HOLDINGS, INC. FILES (8-K) Disclosing Change in Directors or Principal Officers, Financial Statements and Exhibits

Edgar Glimpses |

Item 5.02. Departure of Directors or Certain Officers; Appointment of Certain

Officers; Compensatory Arrangements of Certain Officers.

On June 25, 2014, the Board of Directors (the "Board") of Vape Holdings, Inc., a Delaware corporation (the "Company"), appointed Allan Viernes to the position of Chief Financial Officer. Mr. Viernes replaces Kyle Tracey who remains Chief Executive Officer and Chairman of the Board and had held the position of Chief Financial Officer on an interim basis.

Mr. Viernes, 28, is an accounting and financial advisor specializing in public company accounting, SEC matters, and financial modelling/analysis. Mr. Viernes previously served as Chief Financial Officer of Sustainable Environmental Technologies Corporation and as Controller for Sendio, Inc. and Bacchus Development. Mr. Viernes has past experience as an auditor with McKennon Wilson & Morgan, a public accounting firm, from 2006 to 2009 focusing on audits of private and publicly-held companies. Mr. Viernes is also a Certified Public Accountant.

Mr. Viernes does not have a material interest in any transaction that is required to be disclosed under Item 404(a) of Regulation S-K. There is no arrangement or understanding between Mr. Viernes and any other person pursuant to which he was selected as the Chief Financial Officer.

Mr. Viernes' Executive Employment Agreement is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

Exhibit No. Description 99.1 Executive Employment Agreement, dated June 25, 2014, by and between the Company and Allan Viernes. 2

--------------------------------------------------------------------------------

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
USPR U.S. Precious Metals Inc 0.00 -0.00 -9.62 3,500

Comments

Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…

Snapwire

A peer-to-Peer authentic photo marketplace disrupting the $10B commercial photography industry.